{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:02:55Z","timestamp":1780599775579,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007753","name":"University of Eastern Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Calpeptin, a calpain inhibitor with potential for treating inflammatory diseases, reduces extracellular vesicle (EV) secretion. While adipose tissue is a recognized target of calpeptin, its effects on lipid metabolism remain unknown. We investigated calpeptin\u2019s impact on fatty acid (FA) profiles and metabolic pathways in human Simpson-Golabi-Behmel Syndrome adipocytes and their EVs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adipocytes were treated with 25 or 50 \u00b5M calpeptin, and EVs were isolated from conditioned media (CM) by ultracentrifugation. Immortalized human hepatocytes (IHHs) were pre-treated with 0 or 400 \u00b5M palmitic acid (PA) and subsequently exposed to CM from calpeptin-treated adipocytes. Total lipid FA composition was determined by gas chromatography\u2013mass spectrometry, and gene expression with RNA-sequencing and qPCR, followed by univariate and multivariate statistics and pathway analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Calpeptin reduced EV secretion and arachidonic acid proportions in adipocytes, while also perturbing key metabolic pathways, including those of the dietarily essential polyunsaturated FAs (PUFAs). Potential biomarker candidates associated with calpeptin included C20\u201322 PUFAs (adipocytes) and 23:0 (EVs). Both PA and the secretome from calpeptin-treated adipocytes induced pro-inflammatory responses in IHHs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings suggest that calpeptin may modulate adipocyte lipid metabolism and EV secretion, with associated inflammatory responses in hepatocytes likely mediated by adipocyte\u2011derived secreted factors. These observations warrant further investigation into the potential adverse effects of calpeptin in the context of metabolic diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00011-026-02280-z","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:45:14Z","timestamp":1780598714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calpain inhibition by calpeptin modulates adipocyte lipid metabolism and secretome-mediated inflammatory crosstalk with hepatocytes"],"prefix":"10.1007","volume":"75","author":[{"given":"Johanna","family":"Matilainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanni","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viivi","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2266-2518","authenticated-orcid":false,"given":"Anne-Mari","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Oikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Rilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reijo","family":"K\u00e4kel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna P.","family":"Sihvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petteri","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"2280_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1152\/physrev.00029.2002","volume":"83","author":"DE Goll","year":"2003","unstructured":"Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003;83:731\u2013801.","journal-title":"Physiol Rev"},{"key":"2280_CR2","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd.2016.212","volume":"15","author":"Y Ono","year":"2016","unstructured":"Ono Y, Saido TC, Sorimachi H. Calpain research for drug discovery: Challenges and potential. Nat Rev Drug Discov. 2016;15:854\u201376.","journal-title":"Nat Rev Drug Discov"},{"key":"2280_CR3","doi-asserted-by":"publisher","first-page":"811980","DOI":"10.3389\/fmed.2022.811980","volume":"9","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang H, Cheng M, Shi J, Zhang W, Liu S, et al. Calpain inhibitor calpeptin alleviates ischemia\/reperfusion-induced acute kidney injury via suppressing AIM2 inflammasome and upregulating Klotho protein. Front Med. 2022;9:811980.","journal-title":"Front Med"},{"key":"2280_CR4","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/cas.13024","volume":"107","author":"M Yoshida","year":"2016","unstructured":"Yoshida M, Miyasaka Y, Ohuchida K, Okumura T, Zheng B, Torata N, et al. Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer\u2013stromal interactions in a mouse xenograft model. Cancer Sci. 2016;107:1443\u201352.","journal-title":"Cancer Sci"},{"key":"2280_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1365-2249.2010.04257.x","volume":"162","author":"C Tabata","year":"2010","unstructured":"Tabata C, Tabata R, Nakano T. The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice. Clin Exp Immunol. 2010;162:560\u20137.","journal-title":"Clin Exp Immunol"},{"key":"2280_CR6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s12035-015-9255-6","volume":"52","author":"S Samantaray","year":"2015","unstructured":"Samantaray S, Knaryan VH, Shields DC, Cox AA, Haque A, Banik NL. Inhibition of calpain activation protects MPTP-induced nigral and spinal cord neurodegeneration, reduces inflammation, and improves gait dynamics in mice. Mol Neurobiol. 2015;52:1054\u201366.","journal-title":"Mol Neurobiol"},{"key":"2280_CR7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/jdi.14292","volume":"15","author":"L Qiao","year":"2024","unstructured":"Qiao L, Yi S, Li T, Pan X, Wang G, Liu X, et al. Calpeptin improves the cognitive function in Alzheimer\u2019s disease-like complications of diabetes mellitus rats by regulating TXNIP\/NLRP3 inflammasome. J Diabetes Investig. 2024;15:1365\u201376.","journal-title":"J Diabetes Investig"},{"key":"2280_CR8","doi-asserted-by":"publisher","first-page":"14398","DOI":"10.1038\/s41598-017-14719-9","volume":"7","author":"L Muniappan","year":"2017","unstructured":"Muniappan L, Javidan A, Jiang W, Mohammadmoradi S, Moorleghen JJ, Katz WS, et al. Calpain inhibition attenuates adipose tissue inflammation and fibrosis in diet-induced obese mice. Sci Rep. 2017;7:14398.","journal-title":"Sci Rep"},{"key":"2280_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/bj20030681","volume":"376","author":"DS Paul","year":"2003","unstructured":"Paul DS, Harmon AW, Winston CP, Patel YM. Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem J. 2003;376:625\u201332.","journal-title":"Biochem J"},{"key":"2280_CR10","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1007\/s00125-016-4102-5","volume":"59","author":"T Yuasa","year":"2016","unstructured":"Yuasa T, Amo-Shiinoki K, Ishikura S, Takahara M, Matsuoka T, Kaneto H, et al. Sequential cleavage of insulin receptor by calpain 2 and \u03b3-secretase impairs insulin signalling. Diabetologia. 2016;59:2711\u201321.","journal-title":"Diabetologia"},{"key":"2280_CR11","unstructured":"Matilainen J, Foster S, Berg V, Tampio J, Turunen T, Mustonen A-M, et al. Calpeptin reduces extracellular vesicle secretion and induces anti-inflammatory effects but upregulates HO-1 and alters adiponectin levels in human adipocytes. J Extracell Biol., in revision."},{"key":"2280_CR12","doi-asserted-by":"publisher","first-page":"1703244","DOI":"10.1080\/20013078.2019.1703244","volume":"9","author":"M Catalano","year":"2019","unstructured":"Catalano M, O\u2019Driscoll L. Inhibiting extracellular vesicles formation and release: A review of EV inhibitors. J Extracell Vesicles. 2019;9:1703244.","journal-title":"J Extracell Vesicles"},{"key":"2280_CR13","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.1038\/s41598-018-28363-4","volume":"8","author":"H Wei","year":"2018","unstructured":"Wei H, Malcor J-DM, Harper MT. Lipid rafts are essential for release of phosphatidylserine-exposing extracellular vesicles from platelets. Sci Rep. 2018;8:9987.","journal-title":"Sci Rep"},{"key":"2280_CR14","doi-asserted-by":"publisher","first-page":"837001","DOI":"10.3389\/fphys.2022.837001","volume":"13","author":"ST Bond","year":"2022","unstructured":"Bond ST, Calkin AC, Drew BG. Adipose-derived extracellular vesicles: Systemic messengers and metabolic regulators in health and disease. Front Physiol. 2022;13:837001.","journal-title":"Front Physiol"},{"key":"2280_CR15","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1038\/s41366-022-01199-9","volume":"46","author":"D Tews","year":"2022","unstructured":"Tews D, Brenner RE, Siebert R, Debatin K-M, Fischer-Posovszky P, Wabitsch M. 20 Years with SGBS cells - A versatile in vitro model of human adipocyte biology. Int J Obes. 2022;46:1939\u201347.","journal-title":"Int J Obes"},{"key":"2280_CR16","doi-asserted-by":"publisher","first-page":"24783","DOI":"10.3402\/jev.v3.24783","volume":"3","author":"GV Shelke","year":"2014","unstructured":"Shelke GV, L\u00e4sser C, Gho YS, L\u00f6tvall J. Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum. J Extracell Vesicles. 2014;3:24783.","journal-title":"J Extracell Vesicles"},{"key":"2280_CR17","unstructured":"Foster S. Calpeptin alters adipocyte extracellular vesicle proteome evoking disease-associated events in hepatocytes. MSc Thesis, Department of Environmental and Biological Sciences, Faculty of Science, Forestry and Technology, University of Eastern Finland, 2025."},{"key":"2280_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1665-2681(19)30912-3","volume":"13","author":"NC Ch\u00e1vez-Tapia","year":"2014","unstructured":"Ch\u00e1vez-Tapia NC, Rosso N, Uribe M, Bojalil R, Tiribelli C. Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes. Ann Hepatol. 2014;13:113\u201320.","journal-title":"Ann Hepatol"},{"key":"2280_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s13105-024-01042-x","volume":"80","author":"S Aggarwal","year":"2024","unstructured":"Aggarwal S, Rastogi A, Maiwall R, Sevak JK, Yadav V, Maras J, et al. Palmitic acid causes hepatocyte inflammation by suppressing the BMAL1-NAD+-SIRT2 axis. J Physiol Biochem. 2024;80:845\u201364.","journal-title":"J Physiol Biochem"},{"key":"2280_CR20","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.3390\/ijms23105613","volume":"23","author":"A-M Mustonen","year":"2022","unstructured":"Mustonen A-M, Paakkonen T, Matilainen J, Rilla K, K\u00e4kel\u00e4 R, Malinen M, et al. Fatty acid fingerprints and hyaluronic acid in extracellular vesicles from proliferating human fibroblast-like synoviocytes. Int J Mol Sci. 2022;23:5613.","journal-title":"Int J Mol Sci"},{"key":"2280_CR21","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s10067-025-07491-z","volume":"44","author":"A-M Mustonen","year":"2025","unstructured":"Mustonen A-M, Savinainen J, Lehtonen M, Lehenkari P, K\u00e4\u00e4ri\u00e4inen T, Joukainen A, et al. Synovial fluid o-tyrosine is a potential biomarker for autoimmune-driven rheumatoid arthritis. Clin Rheumatol. 2025;44:2657\u201368.","journal-title":"Clin Rheumatol"},{"key":"2280_CR22","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: Protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u201346","journal-title":"Nucleic Acids Res"},{"key":"2280_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11926-021-01007-9","volume":"23","author":"A-M Mustonen","year":"2021","unstructured":"Mustonen A-M, Nieminen P. Fatty acids and oxylipins in osteoarthritis and rheumatoid arthritis\u2014A complex field with significant potential for future treatments. Curr Rheumatol Rep. 2021;23:41.","journal-title":"Curr Rheumatol Rep"},{"key":"2280_CR24","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/jn\/135.8.1841","volume":"135","author":"KM Ajuwon","year":"2005","unstructured":"Ajuwon KM, Spurlock ME. Palmitate activates the NF-\u03baB transcription factor and induces IL-6 and TNF\u03b1 expression in 3T3-L1 adipocytes. J Nutr. 2005;135:1841\u20136.","journal-title":"J Nutr"},{"key":"2280_CR25","doi-asserted-by":"publisher","first-page":"663838","DOI":"10.3389\/fnut.2021.663838","volume":"8","author":"D Sergi","year":"2021","unstructured":"Sergi D, Luscombe-Marsh N, Naumovski N, Abeywardena M, O\u2019Callaghan N. Palmitic acid, but not lauric acid, induces metabolic inflammation, mitochondrial fragmentation, and a drop in mitochondrial membrane potential in human primary myotubes. Front Nutr. 2021;8:663838.","journal-title":"Front Nutr"},{"key":"2280_CR26","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1002\/1878-0261.13223","volume":"16","author":"MIY Elmallah","year":"2022","unstructured":"Elmallah MIY, Ortega-Deballon P, Hermite L, Pais-De-Barros J-P, Gobbo J, Garrido C. Lipidomic profiling of exosomes from colorectal cancer cells and patients reveals potential biomarkers. Mol Oncol. 2022;16:2710\u20138.","journal-title":"Mol Oncol"},{"key":"2280_CR27","doi-asserted-by":"publisher","first-page":"159602","DOI":"10.1016\/j.bbalip.2025.159602","volume":"1870","author":"A-M Mustonen","year":"2025","unstructured":"Mustonen A-M, Julkunen P, S\u00e4is\u00e4nen L, Karttunen L, Esrafilian A, Reijonen J, et al. Pain and functional limitations in knee osteoarthritis are reflected in the fatty acid composition of plasma extracellular vesicles. Biochim Biophys Acta Mol Cell Biol Lipids. 2025;1870:159602.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2280_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.addr.2020.03.002","volume":"159","author":"T Skotland","year":"2020","unstructured":"Skotland T, Sagini K, Sandvig K, Llorente A. An emerging focus on lipids in extracellular vesicles. Adv Drug Deliv Rev. 2020;159:308\u201321.","journal-title":"Adv Drug Deliv Rev"},{"key":"2280_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12967-024-05249-w","volume":"22","author":"J Matilainen","year":"2024","unstructured":"Matilainen J, Berg V, Vaittinen M, Impola U, Mustonen A-M, M\u00e4nnist\u00f6 V, et al. Increased secretion of adipocyte-derived extracellular vesicles is associated with adipose tissue inflammation and the mobilization of excess lipid in human obesity. J Transl Med. 2024;22:623.","journal-title":"J Transl Med"},{"key":"2280_CR30","doi-asserted-by":"publisher","first-page":"29159","DOI":"10.3402\/jev.v4.29159","volume":"4","author":"KD Connolly","year":"2015","unstructured":"Connolly KD, Guschina IA, Yeung V, Clayton A, Draman MS, Von Ruhland C, et al. Characterisation of adipocyte-derived extracellular vesicles released pre- and post-adipogenesis. J Extracell Vesicles. 2015;4:29159.","journal-title":"J Extracell Vesicles"},{"key":"2280_CR31","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.bbalip.2019.06.010","volume":"1864","author":"M Holopainen","year":"2019","unstructured":"Holopainen M, Colas RA, Valkonen S, Tigistu-Sahle F, Hyv\u00e4rinen K, Mazzacuva F, et al. Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864:1350\u201362.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2280_CR32","unstructured":"Ridgway ND, McLeod RS, editors. In: Biochemistry of lipids, lipoproteins and membranes, 6th edition. Amsterdam: Elsevier; 2016."},{"key":"2280_CR33","doi-asserted-by":"publisher","first-page":"101953","DOI":"10.1016\/j.jbc.2022.101953","volume":"298","author":"R Akasu","year":"2022","unstructured":"Akasu R, Miyazaki T, Elhussiny MZ, Sugiura Y, Tomitsuka Y, Haraguchi S, et al. Calpain-mediated proteolytic production of free amino acids in vascular endothelial cells augments obesity-induced hepatic steatosis. J Biol Chem. 2022;298:101953.","journal-title":"J Biol Chem"},{"key":"2280_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/bloodadvances.2018023473","volume":"3","author":"W Jing","year":"2019","unstructured":"Jing W, Yabas M, Br\u00f6er A, Coupland L, Gardiner EE, Enders A, et al. Calpain cleaves phospholipid flippase ATP8A1 during apoptosis in platelets. Blood Adv. 2019;3:219\u201329.","journal-title":"Blood Adv"},{"key":"2280_CR35","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1053\/gast.1996.v110.pm8964416","volume":"110","author":"H Miyoshi","year":"1996","unstructured":"Miyoshi H, Umeshita K, Sakon M, Imajoh-Ohmi S, Fujitani K, Gotoh M, et al. Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide\u2013induced rat hepatocyte injury. Gastroenterology. 1996;110:1897\u2013904.","journal-title":"Gastroenterology"},{"key":"2280_CR36","doi-asserted-by":"publisher","first-page":"e202408159","DOI":"10.1083\/jcb.202408159","volume":"224","author":"JK Williams","year":"2025","unstructured":"Williams JK, Ngo JM, Murugupandiyan A, Croall DE, Hartzell HC, Schekman R. Calpains orchestrate secretion of annexin-containing microvesicles during membrane repair. J Cell Biol. 2025;224:e202408159.","journal-title":"J Cell Biol"},{"key":"2280_CR37","doi-asserted-by":"publisher","first-page":"110441","DOI":"10.1016\/j.jbc.2025.110441","volume":"301","author":"M Caputo","year":"2025","unstructured":"Caputo M, Gubar O, T\u00f3th P, Vitale N, Gasman S, Ory S. Lipid asymmetry and membrane trafficking: Transbilayer distribution of structural phospholipids as regulators of exocytosis and endocytosis. J Biol Chem. 2025;301:110441.","journal-title":"J Biol Chem"},{"key":"2280_CR38","doi-asserted-by":"publisher","first-page":"23893","DOI":"10.1074\/jbc.274.34.23893","volume":"274","author":"G J\u00e9kely","year":"1999","unstructured":"J\u00e9kely G, Friedrich P. Characterization of two recombinant Drosophila calpains. CALPA and a novel homolog, CALPB. J Biol Chem. 1999;274:23893\u2013900.","journal-title":"J Biol Chem"},{"key":"2280_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13578-020-00507-y","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Wang H. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease. Cell Biosci. 2020;10:140.","journal-title":"Cell Biosci"},{"key":"2280_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/fsn3.2002","volume":"9","author":"H Xu","year":"2021","unstructured":"Xu H, Zhang L, Xu D, Deng W, Yang W, Tang F, et al. Knockout of calpain-1 protects against high-fat diet-induced liver dysfunction in mouse through inhibiting oxidative stress and inflammation. Food Sci Nutr. 2021;9:367\u201374.","journal-title":"Food Sci Nutr"},{"key":"2280_CR41","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s42003-023-05317-9","volume":"6","author":"PYA Reinke","year":"2023","unstructured":"Reinke PYA, de Souza EE, G\u00fcnther S, Falke S, Lieske J, Ewert W, et al. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections. Commun Biol. 2023;6:1058.","journal-title":"Commun Biol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02280-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02280-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02280-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:45:16Z","timestamp":1780598716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02280-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2280"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02280-z","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"132"}}